Ganglioside GQ1B AB (IgG), EIA Test
About Ganglioside GQ1B AB (IgG), EIA Test
| Field | Value |
|---|---|
| Also Known As | Anti-GQ1b Antibody Test, GQ1b IgG Antibody, Anti-Ganglioside GQ1b Antibody |
| Sample Type | Serum (venous blood) |
| Fasting Required | Yes, overnight fasting is preferred |
| Report Time | 2 to 3 weeks after sample submission |
| Recommended For | All genders and ages with suspected autoimmune neuropathies |
| Price | Starting at ₹5,100 |
What Is a Ganglioside GQ1B AB (IgG), EIA Test?
The Ganglioside GQ1B AB (IgG), EIA test detects specific immune proteins called IgG antibodies that target ganglioside GQ1b, a molecule found in nerve cell membranes. When these antibodies are present in unusually high amounts, they can signal an autoimmune condition affecting the nervous system. Doctors typically order this test when a patient shows sudden neurological symptoms such as eye movement difficulties, poor coordination, or loss of reflexes. It is also known as the Anti-GQ1b Antibody Test or GQ1b IgG Antibody test.
What Does a Ganglioside GQ1B AB (IgG), EIA Test Measure?
This test analyses a single key marker in the blood. The table below explains what it looks for and why it matters:
| Parameter | What It Measures |
|---|---|
| Anti-GQ1b IgG Antibody | Detects IgG antibodies directed against the ganglioside GQ1b molecule on nerve cell membranes. Raised levels suggest an abnormal immune response targeting the nervous system. |
Why Is a Ganglioside GQ1B AB (IgG), EIA Test Done?
Doctors request this test when a patient's symptoms point towards a rare autoimmune nerve condition. Understanding the reasons helps patients know what to expect.
Common Symptoms That May Require This Test
The following symptoms are among the most common reasons a doctor may recommend the Ganglioside GQ1B AB (IgG), EIA test:
- Sudden weakness or paralysis of the eye muscles (ophthalmoplegia)
- Loss of coordination and balance (ataxia)
- Absent or reduced reflexes (areflexia)
- Double vision or drooping eyelids
- Facial muscle weakness
- Difficulty swallowing
- Tingling, numbness, or weakness in the arms and legs
Conditions This Test Can Help Detect
This test helps doctors identify a specific group of autoimmune nerve disorders. Conditions it can assist in diagnosing include:
- Miller Fisher syndrome (MFS), a variant of Guillain-Barré syndrome marked by eye muscle weakness, poor coordination, and loss of reflexes
- Bickerstaff brainstem encephalitis (BBE), an inflammation of the brainstem affecting consciousness and movement
- Classic Guillain-Barré syndrome (GBS) in patients who also have eye muscle involvement
- Acute ophthalmoplegia and acute ataxic neuropathy (a nerve disorder causing poor coordination)
- Pharyngeal-cervical-brachial weakness
How to Prepare and What to Expect
This is a straightforward blood test, but a few steps help ensure the sample is collected correctly and gives the most accurate result.
Do You Need to Fast?
Yes, overnight fasting is preferred before this test. Avoid eating or drinking anything other than water for at least 8 to 10 hours before your appointment. If you have been prescribed other tests alongside this one, check with your doctor whether fasting applies to those as well.
Practical Tips Before Your Test
A little preparation before your appointment makes the process smoother. Keep the following in mind:
- For the best chance of detecting antibodies, arrange sample collection as close to the onset of your symptoms as possible, ideally within the first four weeks.
- If you have already started immunosuppressant medication or intravenous immunoglobulin (IVIG) treatment, let your doctor know before the test, as these can affect the result.
- Tell your healthcare provider about all medicines, supplements, or vitamins you are currently taking.
- Drink adequate water before your appointment to make the blood draw easier.
- Wear a loose, short-sleeved top so the phlebotomist can access your arm easily.
- Note any recent infections (stomach bugs or respiratory illness) and share this information with your doctor.
Step-by-Step Procedure
Here is what happens during sample collection for the Ganglioside GQ1B AB (IgG), EIA test:
- The phlebotomist cleans a small area on your inner arm with an antiseptic wipe.
- A needle is gently inserted into a vein, and approximately 3 ml of blood is collected into a yellow-top serum separator tube (SST).
- The needle is removed, and gentle pressure is applied to the area to stop any bleeding.
- The tube is labelled, and the blood is allowed to clot before being spun in a centrifuge to separate the serum.
- The serum sample is stored at refrigerated temperature (2 to 8°C) and dispatched to the specialised laboratory.
- The sample is tested using an enzyme immunoassay (EIA) method. Note that samples must be submitted by the 7th of the month, with the report available after 2 to 3 weeks.
Factors That Can Affect Accuracy
Several factors may influence how reliable your results are. These include:
- Starting immunotherapy (such as IVIG or plasma exchange) before sample collection, which can reduce antibody levels
- Delay in sample collection (antibodies typically clear within 4 to 5 weeks of the acute phase)
- Recent infections, which may alter immune activity
- Dehydration, which can affect sample quality
- Failure to disclose current medications to the doctor or phlebotomist
Understanding Your Ganglioside GQ1B AB (IgG), EIA Test Results
Results for this test are reported as either negative or positive (sometimes expressed as a titre value). Your doctor will interpret these findings alongside your symptoms and clinical history.
The table below provides a general guide to reference values:
| Parameter | Negative (Normal) | Positive (Raised) |
|---|---|---|
| GQ1b IgG Antibody Titre | Less than 1:100 | 1:100 or above |
These ranges are general guidelines. Your doctor will interpret your results based on your age, health history, and other factors. Always consult a qualified healthcare professional for personalised medical advice.
- A positive result may point towards Miller Fisher syndrome, Bickerstaff brainstem encephalitis, or Guillain-Barré syndrome with eye muscle involvement.
- A negative result means no IgG antibodies against ganglioside GQ1b were detected. However, a negative result does not completely rule out an autoimmune nerve condition, particularly if the sample was collected late in the illness.
Results During Special Conditions
Certain situations can influence how results are interpreted:
- Prior immunotherapy use: If IVIG or plasma exchange was started before sample collection, antibody levels may already be falling, reducing the test's ability to detect a positive result.
- Recent infection: A preceding viral or bacterial infection (such as Campylobacter jejuni, a gut infection) occurs in the majority of cases and may be relevant context for your doctor when reading results.
- Late-stage collection: Anti-GQ1b antibodies typically become undetectable within 4 to 5 weeks after the acute phase, so a negative result in this window may not reflect the situation at disease onset.
How to Maintain Healthy Levels
These are general wellness tips, not treatment recommendations. Always follow your doctor's specific guidance:
- Seek prompt medical attention if you experience sudden eye movement difficulties, balance problems, or loss of reflexes, especially after a recent infection.
- Support overall immune health through balanced nutrition, adequate rest, and regular physical activity.
- Always inform your doctor about any recent gastrointestinal or respiratory infections before undergoing this test.
Lupin Diagnostics Ganglioside GQ1B AB (IgG), EIA Test Price and Home Collection
The Ganglioside GQ1B AB (IgG), EIA test is available at Lupin Diagnostics starting at ₹5,100, with home sample collection available across cities.
The table below provides indicative prices in major Indian cities:
| City | Approximate Price (₹) |
|---|---|
| BHOPAL | 5100 |
| CHENNAI | 5100 |
| HYDERABAD | 5100 |
| KOLKATA | 5100 |
| NAVI MUMBAI | 5100 |
| PUNE | 5100 |
Prices are indicative and may vary by location. Please confirm the current price at the time of booking.
How to Book
Booking your Ganglioside GQ1B AB (IgG), EIA test at Lupin Diagnostics is straightforward:
- Select the test on the Lupin Diagnostics website.
- Choose your city and preferred time slot.
- Opt for home sample collection by a certified phlebotomist, or visit your nearest Lupin Diagnostics centre.
- Receive your report via email or WhatsApp within the stipulated turnaround time.
Home Collection
Home collection for the Ganglioside GQ1B AB test is available across major cities. A trained phlebotomist visits your home at a convenient time, collects the blood sample, and dispatches it to a NABL-accredited Lupin Diagnostics laboratory for processing. Your digital report is shared directly with you once ready.
Frequently Asked Questions
This test helps doctors diagnose autoimmune nerve conditions, particularly Miller Fisher syndrome and related disorders. It detects IgG antibodies targeting the ganglioside GQ1b molecule on nerve cells. The Ganglioside GQ1B AB test is ordered when a patient shows symptoms such as sudden eye muscle weakness, poor coordination, or absent reflexes.
Miller Fisher syndrome is a rare variant of Guillain-Barré syndrome. It is characterised by three key features: weakness of the eye muscles (ophthalmoplegia), loss of coordination (ataxia), and absent tendon reflexes. Most patients with this condition test positive for anti-GQ1b IgG antibodies.
For the most accurate result, the Ganglioside GQ1B AB, EIA test should be done as close to the start of symptoms as possible, ideally within the first four weeks. Anti-GQ1b antibodies tend to become undetectable around 4 to 5 weeks after the acute phase of illness.
Yes. Conditions like Miller Fisher syndrome are often triggered by an abnormal immune response following infections such as Campylobacter jejuni (a gut bacterial infection), cytomegalovirus, or Epstein-Barr virus. Your doctor will ask about any recent illnesses when reviewing your results.
Not entirely. A negative result does not completely exclude an autoimmune nerve condition. If the sample was collected after antibodies had already cleared or after immunotherapy was started, the result may appear negative even when the condition is present. Your doctor will consider the full clinical picture alongside the test result.
A positive result suggests the presence of IgG antibodies against ganglioside GQ1b. This finding is associated with Miller Fisher syndrome, Bickerstaff brainstem encephalitis, and Guillain-Barré syndrome with eye muscle involvement. Your doctor will interpret the result in context with your symptoms and other investigations.
Yes, the Ganglioside GQ1B AB, EIA test can be booked online through the Lupin Diagnostics website. Home sample collection is available, where a trained phlebotomist visits your home to collect the blood sample. Please note that samples must reach the laboratory by the 7th of the month, so plan your booking accordingly.
Ganglioside GQ1B AB (IgG), EIA Test
